Local allergic rhinitis often progresses over time

August 31, 2017

(HealthDay)—Patients with local allergic rhinitis (LAR) show worsening of rhinitis, greater tendency toward development of asthma, and impairment of quality of life after 10 years, but have a similar rate of development of allergic rhinitis with systemic atopy as controls, according to research published online Aug. 22 in Allergy.

Carmen Rondon, M.D., Ph.D., from the IBIMA-Regional University Hospital of Málaga in Spain, and colleagues examined the natural history of a population with LAR in a 10-year follow-up study of a cohort of 176 with LAR of recent onset and 115 age- and sex-matched controls.

The researchers found that LAR patients experienced a significant and clinically relevant worsening of the rhinitis after 10 years, with increase of emergency assistance, development of asthma, loss of allergen tolerance, and impairment of quality of life. After five years, the worsening became significant, and progressed throughout 10 years. Patients and controls had a similar rate of development of with systemic atopy (9.7 versus 7.8 percent; P = 0.623). Conversion to systemic atopic occurred after 10 years in five patients (3 percent).

"LAR is a well-differentiated clinical entity with a low rate of of systemic atopy, a natural evolution towards worsening, and a risk factor for suffering asthma," the authors write.

Explore further: Cost-effectiveness of allergen immunotherapy evaluated

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Cost-effectiveness of allergen immunotherapy evaluated

July 31, 2017
(HealthDay)—Allergen immunotherapy (AIT) may be cost-effective for allergic rhinitis, and for venom allergy in high-risk subgroups, according to research published online July 18 in Allergy.

BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis

July 10, 2017
The Standards of Care Committee of the British Society for Allergy & Clinical Immunology (BSACI) is to publish updated guidance on the diagnosis and management of allergic and non-allergic rhinitis. Allergic rhinitis is common ...

Study examines prevalence of local allergic rhinitis

September 25, 2012
(HealthDay)—Local allergic rhinitis (LAR) is prevalent among patients with rhinitis, affecting about one in four, and is often associated with childhood onset and persistent, severe conjunctivitis and/or asthma, according ...

Local allergic rhinitis responds to allergen immunotherapy

March 29, 2016
(HealthDay)—Dermatophagoides pteronyssinus (DP) subcutaneous allergen immunotherapy (AIT) seems safe and effective for local allergic rhinitis (LAR), according to a study published online March 23 in Allergy.

Nasal allergies tied to increased nasopharyngeal cancer risk

February 24, 2015
(HealthDay)—Patients with allergic rhinitis may have an increased risk of developing nasopharyngeal carcinoma (NPC), according to a Taiwanese study published in the March issue of Head & Neck.

Perceived stress linked to asthma, atopic disorders

September 21, 2012
(HealthDay)—Perceived stress correlates with an increased risk of adult-onset asthma, allergic rhinitis, and atopic dermatitis as well as asthma medication use, according to a study published online Sept. 3 in Allergy.

Recommended for you

New findings suggest allergic responses may protect against skin cancer

July 17, 2018
The components of the immune system that trigger allergic reactions may also help protect the skin against cancer, suggest new findings.

The immune system: T cells are built for speed

July 17, 2018
Without T cells, we could not survive. They are a key component of the immune system and have highly sensitive receptors on their surface that can detect pathogens. The exact way that these receptors are distributed over ...

Broadly acting antibodies found in plasma of Ebola survivors

July 17, 2018
Recent Ebola virus disease (EVD) outbreaks, including the 2013-2016 epidemic that ravaged West Africa and the 2018 outbreak in the Democratic Republic of the Congo, highlight the need for licensed treatments for this often-deadly ...

How protein fragments could help to tackle the cause of hay fever

July 16, 2018
Imperial researchers are looking to protein fragments to help people build up resistance to grass pollen.

Team explores diabetes drug's ability to treat RSV infection

July 13, 2018
A drug used to treat diabetes may point to new therapies for respiratory syncytial virus (RSV) bronchiolitis—inflammation and obstruction of the lungs' small airways. A multi-disciplinary team of Vanderbilt investigators ...

Testing suggests TORC1 inhibitors can boost immune system in the elderly

July 12, 2018
A team of researchers affiliated with Novartis Institutes for Biomedical Research and Biometrics Matters Limited, has found via testing with volunteers that TORC1 inhibitors can boost the immune system in the elderly. In ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.